CTLA4 and cancer: In this study, we further defined the mechanisms by which T cells modulate tumor vasculature and TA-HEVs, and we identified how antibody Fc effector function regulates this activity in the setting of anti-CTLA-4 therapy, informing therapeutic opportunities for the modulation of tumor blood vessels and TA-HEVs in patients with cancer.